(opens in new tab)Skip to main content

Cancer Center - Mile High

Loading hours...

This department offers

  • Cancer care

Our providers

Mary Jane LaRoche

Mary Jane LaRoche, NP

Hematology
Intermountain Health Cancer Center - Mile High
303-403-6820
Jeffrey T. Owsley
4.9

Jeffrey T. Owsley, DO

Breast Medical Oncology
Lutheran Hospital - Cancer Centers of CO Medical Oncology
Amity D. Helzer
5

Amity D. Helzer, PA

Hematology Oncology
Intermountain Health Cancer Center - Mile High
Slide 1 of 3

You might be interested in

Discover the inspiring journey of Rebekah Louder, a single mother of four, who defied a devastating leukemia diagnosis with unwavering hope, faith, and the support of her family

Understanding your risks and exploring your screening options are vital steps in preventing colon cancer

Now two years since completing her chemotherapy and in remission, Julie’s story is a testament to the strength and resilience of women facing breast cancer.

Addressing the rising trend of earlier colon cancer diagnoses

There are 3 main goals for treating cancer: cure, control, and comfort. When cancer is in the early stages, cure is often possible. When cancer has spread beyond where it started, the goal is to shrink a tumor and control cancer growth.

One in seven men will be diagnosed with prostate cancer during his lifetime with 60 percent of those cases occurring in men age 65 or older. Prostate cancer is rare before age 40, and the average age at diagnosis is 66. 

Are you at risk for breast cancer? Take our breast cancer risk quiz today.

The future of cancer treatment looks promising at Intermountain Healthcare. That’s because Intermountain’s physicians and researchers are using precision genomics to provide a personalized approach to testing, diagnosing and treating cancer.

Working with breast cancer patients is both challenging and incredibly rewarding. While watching my patients suffer can be tough, I am often inspired by their strength, resolve and selflessness.

In case you missed it: latest advances in cancer research discussed at most recent Research Colloquium

Slide 1 of 10